Involvement of inhibitory NKRs in the survival of a subset of memory-phenotype CD8+ T cells

被引:157
作者
Ugolini, S
Arpin, C
Anfossi, N
Walzer, T
Cambiaggi, A
Förster, R
Lipp, M
Toes, REM
Melief, CJ
Marvel, J
Vivier, E
机构
[1] CNRS Marseille Luminy, INSERM, Ctr Immuno, F-13288 Marseille 09, France
[2] INSERM, U503, CERVI, Lyon, France
[3] Univ Oxford, Sir William Dunn Sch Pathol, Oxford, England
[4] Max Delbruck Ctr Mol Med, Berlin, Germany
[5] Leiden Univ, Ctr Med, Dept Immunohaematol & Bloodbank, Leiden, Netherlands
关键词
D O I
10.1038/87740
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Inhibitory natural killer receptors (NKRs) such as killer cell immunoglobulin-like receptors (KIRs) in humans and Ly49 molecules in mice are expressed on NK cells and recognize multiple major histocompatibility (MHC) class I proteins. In humans and mice, a subset of CD8(+)T cells also expresses NKRs and harbors a memory phenotype. Using mice that are transgenic for KIR2DL3 and its cognate HLA-Cw3 ligand, we show that engagement of inhibitory NKRs selectively drives the in vivo accumulation of a subset of memory-phenotype CD8(+) T cells that express the beta chain of the interleukin 2 receptor. In vitro, recognition of MHC class I molecules by inhibitory NKRs on T cells down-regulated activation-induced cell death. These results unveil an MHC class I-dependent pathway that promotes the survival of a subset of memory-phenotype CD8(+)T cells and also reveal an unexpected biological function for inhibitory NKRs on T cells.
引用
收藏
页码:430 / 435
页数:6
相关论文
共 30 条
[1]  
ANFOSSI N, 2001, IN PRESS IMMUNOL REV, V181
[2]  
Bieganowska K, 1999, J IMMUNOL, V162, P1765
[3]  
Borges L, 1999, CURR TOP MICROBIOL, V244, P123
[4]  
BUDD RC, 1987, J IMMUNOL, V138, P3583
[5]   Modulation of T-cell functions in KIR2DL3 (CD158b) transgenic mice [J].
Cambiaggi, A ;
Darche, S ;
Guia, S ;
Kourilsky, P ;
Abastado, JP ;
Vivier, E .
BLOOD, 1999, 94 (07) :2396-2402
[6]   Natural killer cell acceptance of H2 mismatch bone marrow grafts in transgenic mice expressing HLA-Cw3 specific killer cell inhibitory receptor (CD158b) [J].
Cambiaggi, A ;
Verthuy, C ;
Naquet, P ;
Romagne, F ;
Ferrier, P ;
Biassoni, R ;
Moretta, A ;
Moretta, L ;
Vivier, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (15) :8088-8092
[7]   The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18 [J].
Chapman, TL ;
Heikema, AP ;
Bjorkman, PJ .
IMMUNITY, 1999, 11 (05) :603-613
[8]  
Coles MC, 2000, EUR J IMMUNOL, V30, P236, DOI 10.1002/1521-4141(200001)30:1<236::AID-IMMU236>3.0.CO
[9]  
2-X
[10]   A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells [J].
Colonna, M ;
Navarro, F ;
Bellon, T ;
Llano, M ;
Garcia, P ;
Samaridis, J ;
Angman, L ;
Cella, M ;
LopezBotet, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (11) :1809-1818